Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 11Development and Manufacturing Services Agreement • November 5th, 2015 • Radius Health, Inc. • Pharmaceutical preparations
THIS WORK ORDER NO. 11 is by and between RADIUS HEALTH, INC. (“RADIUS”) and LONZA Sales Ltd, a Swiss company having an address at Muenchensteinerstrasse 38, CH-4002 Basel, Switzerland (together with its Affiliates, “Manufacturer”), and upon execution will be incorporated into the Development and Manufacturing Services Agreement between RADIUS and Manufacturer dated October 16, 2007 (the “Agreement”). Capitalized terms in this Work Order will have the same meanings as set forth in the Agreement.
Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 12Development and Manufacturing Services Agreement • November 5th, 2015 • Radius Health, Inc. • Pharmaceutical preparations
THIS WORK ORDER NO. 12 is by and between RADIUS HEALTH, INC. (“RADIUS”) and LONZA Sales Ltd, a Swiss company having an address at Muenchensteinerstrasse 38, CH-4002 Basel, Switzerland (together with its Affiliates, “Manufacturer”), and upon execution will be incorporated into the Development and Manufacturing Services Agreement between RADIUS and Manufacturer dated October 16, 2007 (the “Agreement”). Capitalized terms in this Work Order will have the same meanings as set forth in the Agreement.
FIRST AMENDMENT TO LEASELease • November 5th, 2015 • Radius Health, Inc. • Pharmaceutical preparations
FIRST AMENDMENT TO LEASE dated as of this 9th day of September, 2015 (the “First Amendment”) by and between BP BAY COLONY LLC, a Delaware limited liability company (“Landlord”), and RADIUS HEALTH, INC., a Delaware corporation (“Tenant”).
Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 240-24b-2 Change Order Form # 23 version 2Change Order • November 5th, 2015 • Radius Health, Inc. • Pharmaceutical preparations
Project Name: For the development of Radius’ Abaloparatide compound delivered via 3M’s Microstructured Transdermal Delivery System
AMENDMENT N°6 TO PHARMACEUTICAL DEVELOPMENT AGREEMENTPharmaceutical Development Agreement • November 5th, 2015 • Radius Health, Inc. • Pharmaceutical preparations • New York
BEAUFOUR IPSEN INDUSTRIE S.A.S., a French corporation incorporated under the laws of France, located at rue d’Ethe Virton, 28100, France, duly represented by Joel Richard, Senior Vice-President, Peptides Development and CMC Dreux,
Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 13Work Order • November 5th, 2015 • Radius Health, Inc. • Pharmaceutical preparations
THIS WORK ORDER NO. 13 is by and between RADIUS HEALTH, INC. (“RADIUS”) and LONZA Sales Ltd, a Swiss company having an address at Muenchensteinerstrasse 38, CH-4002 Basel, Switzerland (together with its Affiliates, “Manufacturer”), and upon execution will be incorporated into the Development and Manufacturing Services Agreement between RADIUS and Manufacturer dated October 16, 2007 (the “Agreement”). Capitalized terms in this Work Order will have the same meanings as set forth in the Agreement.
